As the Executive Director of Strategic Partnerships, Vanessa works with a variety of stakeholders to build collaborative relationships and innovative initiatives that meaningfully benefit the amyloidosis community. Vanessa brings over 15 years of experience centering cross-sector collaboration in pursuit of health and social equity to her position at ARC. She currently is an appointed member of the Patient-Centered Outcomes Research Institute (PCORI) Advisory Panel on Rare Diseases and prior to joining ARC was the inaugural Director of Research at the National Organization for Rare Disorders (NORD).
Transforming Urban Cardiovascular Health
At the 2025 Concordia Annual Summit, leaders from across sectors gathered to address one of the most pressing global health challenges: cardiovascular disease in rapidly growing urban environments. In partnership with
